← Back
Data updated: Mar 10, 2026
VIWIT PHARM
Cardiovascular
VIWIT PHARM is a generic drug manufacturer focused on Cardiovascular.
2009
Since
4
Drugs
-
Trials
145
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VARENICLINE TARTRATE 2026-01-09
VARENICLINE TARTRATE 2025-12-18
Labeling
NITROGLYCERIN 2025-12-18
LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
VARENICLINE TARTRATE 2025-10-29
VARENICLINE TARTRATE 2025-09-24
Labeling
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-12
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2009-03-13
- Latest
- 2025-05-06
- Applications
- 4